You just read:

Ivantis FDA Clinical Trial of the Hydrus® Microstent for Minimally Invasive Glaucoma Surgery (MIGS) Meets Endpoints, Exceeds Outcomes of Past MIGS Trials

News provided by

Ivantis, Inc.

Nov 13, 2017, 08:05 EST